Skip to main content
SoftOx Solutions AS logo

SoftOx Solutions AS — Investor Relations & Filings

Ticker · SOFTX ISIN · NO0010811961 LEI · 549300AETMWJS91G4A50 OL Manufacturing
Open in API
Filings indexed 572 across all filing types
Latest filing 2020-12-18 Share Issue/Capital Cha…
Country NO Norway
Listing OL SOFTX

About SoftOx Solutions AS

https://soft-ox.com/

SoftOx Solutions AS is a clinical-stage pharmaceutical company that has developed a patented, non-toxic antimicrobial technology. The technology is based on a stabilized formulation of hypochlorous acid (HOCl), an endogenous molecule used by the human immune system to combat pathogens. It is designed to be highly effective against a broad spectrum of bacteria, viruses, and fungi, and to eradicate and prevent biofilm infections. A key feature of the technology is that its mode of action does not induce antimicrobial resistance (AMR). The company's development pipeline focuses on significant health challenges, with a lead candidate, SoftOx Inhalation Solution (SIS), for treating airway infections, as well as other applications in wound care and disinfection.

Recent filings

Filing Released Lang Actions
SoftOx Solutions AS: Raised NOK 50 million after stock exchange closing Wednesday December 16th - More than 100% oversubscribed
Share Issue/Capital Change Classification · 99% confidence The document announces that SoftOx Solutions AS successfully raised NOK 50 million through a private placement, which was oversubscribed. It details the structure of the capital increase (two tranches) and mentions a proposed 'repair issue' directed at shareholders who missed the initial placement. This content directly relates to fundraising, capital structure changes, and financing activities. Based on the definitions, this clearly falls under 'Capital/Financing Update' (Code: CAP). The document length (2612 chars) is not indicative of a full report, but the content is a direct announcement of a financing event, not just an announcement of a report's publication.
2020-12-18 English
SoftOx Solutions AS: Key information relating to the repair issue to be carried out by SoftOx Solutions AS
Capital/Financing Update Classification · 98% confidence The document announces key information regarding a potential 'Subsequent Offering' of new shares following a completed 'Private Placement'. It details dates related to the offering (last day including right, ex-date, record date, date of approval) and the maximum number of new shares and subscription price. This content directly relates to fundraising, capital structure changes, and the issuance of new securities. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). Although it involves share issuance, the primary focus is the financing event (the offering) rather than just the resulting share change (SHA) or insider trading (DIRS). Given the context of a planned offering contingent on shareholder approval, it is a financing announcement.
2020-12-16 English
SoftOx Solutions AS: Key information relating to the repair issue to be carried out by SoftOx Solutions AS
Share Issue/Capital Change Classification · 99% confidence The document is very short (1235 characters) and explicitly states, 'See attachment for further details.' It references a prior announcement about a 'private placement' and a 'potential subsequent offering' of shares. This structure—a brief announcement pointing to a more detailed attachment—strongly suggests it is an announcement about the publication of information rather than the full report itself. Since the content relates to fundraising and capital structure changes (Private Placement/Subsequent Offering), the most fitting category is Capital/Financing Update (CAP). However, given the 'See attachment' language and short length, it could also be a Report Publication Announcement (RPA). Since the core subject matter is financing, CAP is more specific, but RPA aligns better with the 'MENU VS MEAL' rule for short announcements pointing to attachments. Given the context of a share issuance/offering, it is fundamentally a financing event. I will classify it as CAP because the subject matter is financing, but acknowledge the RPA characteristic. Since the document is about a 'private placement' and a 'subsequent offering,' which are capital activities, CAP is the primary classification, even if it's presented as a brief notice.
2020-12-16 English
SoftOx Solutions AS: Private placement successfully completed
Share Issue/Capital Change Classification · 99% confidence The document is an announcement titled "SoftOx Solutions AS: Private placement successfully completed." It details the raising of NOK 50 million through the issuance of new shares (Offer Shares) via a private placement, mentioning tranches, settlement dates, use of proceeds (clinical studies), and a proposed Subsequent Offering requiring an Extraordinary General Meeting (EGM) approval. This content directly relates to fundraising, capital structure changes, and the issuance of new securities. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it describes a specific corporate financing action.
2020-12-16 English
SoftOx Solutions AS: Contemplated private placement
Share Issue/Capital Change Classification · 99% confidence The document is an announcement titled "SoftOx Solutions AS: Contemplated private placement". It details the intention to raise capital (NOK 30 to 50 million) through the issuance of new shares via a private placement, involving an accelerated book building process and subsequent shareholder approval (EGM) for Tranche 2. This activity directly relates to fundraising, capital structure changes, and the issuance of new shares, which falls under the 'Capital/Financing Update' category (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it describes a specific corporate financing action.
2020-12-16 English
Københavns Universitet og SoftOx Solutions rapporterer om positive resultater med SoftOx Inhalation Solution (SIS)
Regulatory Filings Classification · 95% confidence The document is a press release dated December 16, 2020, announcing positive safety study results for SoftOx Inhalation Solution (SIS) from collaborations between the University of Copenhagen and SoftOx Solutions. It discusses safety findings, future human studies, and the potential application for COVID-19 treatment. This type of announcement, focusing on research progress, safety data, and future clinical plans, is typically classified as a general regulatory announcement or news release, rather than a formal financial report (like 10-K or IR) or a specific management/governance filing. Since it is a general announcement of progress that doesn't fit the specific categories like ER (Earnings Release), CAP (Financing), or DIV (Dividend), the most appropriate fallback category is Regulatory Filings (RNS), as it serves as a general regulatory/corporate update.
2020-12-16 Norwegian

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.